Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2022

View Archived Issues

Modulating CYTOR promotes myogenesis in aging

TGFBR3L modulates FSH activity and fertility

Hemagglutinin anchor epitope unveiled as a target of broadly neutralizing antibodies

Compact cell classifiers packaged into AAV vectors for precision tumor cell targeting

MRSA superbug has prickly origins

French researchers patent new antibacterial compounds

Janssen Pharmaceutica discloses Mcl-1 inhibitors

Anaxis Pharma identifies new RIPK1 and/or MLKL inhibitors

Chinese researchers describe new GLP-1 receptor agonists

Life Biosciences to accelerate R&D activities on aging-related programs

Pfizer and BioNTech collaborate on mRNA-based vaccine to prevent shingles

Discovery of novel bergenin derivatives as immunosuppressive agents

Wigen Biomedicine Technology synthesizes new Wee1 inhibitors

RBT-0813 shown to neutralize Omicron and Delta variants of SARS-CoV-2 in live virus studies

Cystic Fibrosis Foundation award supports development of Peptilogics' PLG-0301 and PLG-0206

SalioGen obtains funding to advance research into genetic therapy for cystic fibrosis

Series A financing at ONK Therapeutics to support NK cell therapies through IND-enabling studies

Biomea's menin inhibitor BMF-219 normalizes glucose levels in animal models of type 2 diabetes

JUVA-019 enters preclinical development for inflammatory disease

LA-PAMAM/pmiR-218 polyplex as potential targeted gene therapy against HCC

Enanta expands respiratory virology program with EDP-323 for RSV

Regulating fibrin-neutrophil interaction for controlling periodontitis

Unity Biotechnology eyes IND-enabling studies with pipeline programs in 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...